TY - JOUR
T1 - A case of an anti-SRP myopathy with enlargement of the thymus
AU - Ohta, Rie
AU - Mukaino, Akihiro
AU - Kinoshita, Ikuo
AU - Tsujihata, Mitsuhiro
AU - Suzuki, Shigeaki
PY - 2014
Y1 - 2014
N2 - A 54-year-old female was admitted to our hospital because of the Raynaud phenomenon and muscle weakness of the upper limbs. The neurological findings showed somatic and proximal limb weakness. Laboratory studies showed a high serum creatine kinase level. Computerized tomography (CT) revealed enlargement of the thymus. A muscle biopsy showed a small number of degenerating and regenerating fibers but no inflammatory infiltrations. At first, she was initially treated with a three-day course of intravenous methylprednisolone (1 g/day). However, the weakness progressed and the serum creatine kinase level remained high. She was subsequently treated with a combination of tacrolimus (3 mg/day) and prednisolone, but showed no any improvement of the muscle weakness. Following additional treatment with intravenous immunoglobulin, she showed improvement in her muscle weakness. Further, anti-signal recognition particle antibodies were identified after treatment. There have been no previous reports of myopathy with antibodies against the signal recognition particle and enlargement of the thymus, so we herein report the details of this unique case.
AB - A 54-year-old female was admitted to our hospital because of the Raynaud phenomenon and muscle weakness of the upper limbs. The neurological findings showed somatic and proximal limb weakness. Laboratory studies showed a high serum creatine kinase level. Computerized tomography (CT) revealed enlargement of the thymus. A muscle biopsy showed a small number of degenerating and regenerating fibers but no inflammatory infiltrations. At first, she was initially treated with a three-day course of intravenous methylprednisolone (1 g/day). However, the weakness progressed and the serum creatine kinase level remained high. She was subsequently treated with a combination of tacrolimus (3 mg/day) and prednisolone, but showed no any improvement of the muscle weakness. Following additional treatment with intravenous immunoglobulin, she showed improvement in her muscle weakness. Further, anti-signal recognition particle antibodies were identified after treatment. There have been no previous reports of myopathy with antibodies against the signal recognition particle and enlargement of the thymus, so we herein report the details of this unique case.
KW - Anti-signal recognition particle antibody
KW - Enlargement of the thymus
KW - Intravenous immunoglobulin
KW - Raynaud phenomenon
UR - http://www.scopus.com/inward/record.url?scp=84908676302&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908676302&partnerID=8YFLogxK
U2 - 10.5692/clinicalneurol.54.798
DO - 10.5692/clinicalneurol.54.798
M3 - Article
C2 - 25342013
AN - SCOPUS:84908676302
SN - 0009-918X
VL - 54
SP - 798
EP - 802
JO - Clinical Neurology
JF - Clinical Neurology
IS - 10
ER -